Cargando…
Recent Advances (2015–2020) in Drug Discovery for Attenuation of Pulmonary Fibrosis and COPD
A condition of scarring of lung tissue due to a wide range of causes (such as environmental pollution, cigarette smoking (CS), lung diseases, some medications, etc.) has been reported as pulmonary fibrosis (PF). This has become a serious problem all over the world due to the lack of efficient drugs...
Autores principales: | Dorababu, Atukuri, Maraswami, Manikantha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179756/ https://www.ncbi.nlm.nih.gov/pubmed/37175084 http://dx.doi.org/10.3390/molecules28093674 |
Ejemplares similares
-
Synthesis, pharmacological evaluation and structure-activity relationship of recently discovered enzyme antagonist azoles
por: Dorababu, Atukuri
Publicado: (2020) -
Recent Advances in Idiopathic Pulmonary Fibrosis
por: Park, Sanghoon, et al.
Publicado: (2013) -
Recent advances in phenotypic drug discovery
por: Swinney, David C., et al.
Publicado: (2020) -
Recent Advances in Covalent Drug Discovery
por: Schaefer, Daniel, et al.
Publicado: (2023) -
Recent advances in managing idiopathic pulmonary fibrosis
por: Scelfo, Chiara, et al.
Publicado: (2017)